These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 5317992)

  • 1. Metabolism of warfarin during methandrostenolone treatment.
    Pyörälä K; Myllylä G; Kekki M
    Ann Med Exp Biol Fenn; 1965; 43(2):95-7. PubMed ID: 5317992
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex difference in the clotting factor response to warfarin and in the rate of warfarin metabolism in the rat.
    Pyörälä K
    Ann Med Exp Biol Fenn; 1968; 46(1):23-34. PubMed ID: 5727659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on on blood coagulation factors; factor V and factor VII complex. 3. Responses of factor V and factor VII complex to anticoagulant drugs in endrocrine disorders].
    Kubo K
    Naika Hokan; 1968; 15(5):147-55. PubMed ID: 5750176
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin.
    D'Ambrosio RL; D'Andrea G; Cappucci F; Chetta M; Di Perna P; Brancaccio V; Grandone E; Margaglione M
    Haematologica; 2004 Dec; 89(12):1510-6. PubMed ID: 15590403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of warfarin therapy on activated factor VII clotting activity.
    Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methandrostenolone on nitrogen excretion following open-heart surgery.
    Zingg W
    Can Med Assoc J; 1965 Oct; 93(15):816-7. PubMed ID: 5318132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential dangers in the combined use of methandrostenolone and sodium warfarin.
    Dresdale FC; Hayes JC
    J Med Soc N J; 1967 Nov; 64(11):609-12. PubMed ID: 5237231
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothrombin levels maintained with meprobamate and warfarin. A controlled study.
    Gould L; Michael A; Fisch S; Gomprecht RF
    JAMA; 1972 Jun; 220(11):1460-2. PubMed ID: 4623950
    [No Abstract]   [Full Text] [Related]  

  • 13. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of selective and non-selective inbreeding on the rate of warfarin metabolism in the rat.
    Pyörälä K; Nevanlinna HR
    Ann Med Exp Biol Fenn; 1968; 46(1):35-44. PubMed ID: 5727660
    [No Abstract]   [Full Text] [Related]  

  • 15. Can a simple warfarin initiation scheme predict the maintenance dose in patients with nonrheumatic atrial fibrillation?
    Culhane NS
    J Fam Pract; 2002 Feb; 51(2):175. PubMed ID: 11978219
    [No Abstract]   [Full Text] [Related]  

  • 16. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
    Pabinger-Fasching I
    Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin pharmacogenomics: a big step forward for individualized medicine: enlightened dosing of warfarin.
    Elias DJ; Topol EJ
    Eur J Hum Genet; 2008 May; 16(5):532-4. PubMed ID: 18301451
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged effects of anabolic steroid upon muscular contractile force.
    Ariel G
    Med Sci Sports; 1974; 6(1):62-4. PubMed ID: 4597009
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative pharmacokinetics of coumarin anticoagulants XXXVI: Predicted steady-state patterns of prothrombin complex activity produced by equieffective doses of (R)-(+)- and (S)-(-)-warfarin in humans.
    Wingard LB; Levy G
    J Pharm Sci; 1977 Dec; 66(12):1790-1. PubMed ID: 925953
    [No Abstract]   [Full Text] [Related]  

  • 20. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.